Mont-Saint-Guibert, Belgium – Celyad (Euronext Brussels and Paris, and NASDAQ: CYAD), a leader in the discovery and development of engineered cell therapies, announces its participation in the 15th edition of the European Large & Midcap Event, which will be held in Paris this coming October 7th and 8th.
By participating in this event focusing especially on European midcap companies, Celyad is seizing the opportunity to share its strategy and present its main development programmes to European institutional investors and analysts.
Patrick Jeanmart, Administrative and Financial Director of Celyad, comments: “We are delighted to be participating once again in the Large and Midcap Event. For two years, Celyad has been developing firm ties with European institutional investors. This event is ideal for sharing with them the major advances our company has achieved in recent months in our cardiology and oncology programmes”.